Work

The Dialkylphosphinoyl Motif: Synthetic Access and Applications in Medicinal Chemistry

Year: 2026
Type: article
Abstract: For decades, organophosphorus derivatives of the phosphine oxide class were frequently regarded as unwanted byproducts of classical transformations and remained largely overlooked by applied chemistry. This perception changed markedly following the FDA approval of brigatinib in 2017, the first anticancer drug containing a phosphine oxide moiety. A key contributor to its properties was the dimethylphosphinoyl group, which enabled strong interactions with the biological target. This success renewed interest in dialkylphosphinoyl fragments and stimulated investigations of their chemical space, physicochemical characteristics, and potential applications in drug design. Although several reviews have addressed various aspects of phosphine oxide chemistry, synthetic access to and medicinal chemistry applications of the dialkylphosphinoyl motif have not been systematically considered together. This focused review surveys representative approaches to compounds containing a P(O)R 2 unit with two P─C(sp 3 ) bonds, with particular emphasis on the P(O)Me 2 group. It covers the use of secondary dialkylphosphine oxides and dialkylphosphinites as reagents for installing this motif, selected alternative synthetic approaches, and representative medicinal chemistry studies. The literature discussed spans foundational reports from the 1950s to current developments, without attempting to provide an exhaustive account of phosphine oxide chemistry as a whole.
Language: English
Field: Chemistry
Open Access status: bronze
OpenAlex ID: W4415943933
FWCI:
Cites: 174
Cited by:
Related to: 10